Alderley Park Ventures Ltd investment portfolio

Alderley Analytical is an independent contract research organisation that delivers GLP‑ and GCP‑compliant bioanalytical services—such as mass‑spectrometry, ligand‑binding assays, toxicokinetics, biomarker and immunogenicity analysis—for small‑molecule, peptide, oligonucleotide and large‑molecule projects. Its clients are pharmaceutical, biotechnology and other CRO companies needing support from drug discovery through pre‑clinical safety testing to clinical development.

BIO-IMAGES DRUG DELIVERY LTD, now operating as BDD Pharma Ltd, provides service packages to the drug development industry, offering controlled-release drug delivery methods and the design and management of clinical trials using scintigraphic imaging. They specialize in formulation work and scintigraphic clinical trials, developing technologies for licensing to pharmaceutical and generic companies.